Oxprenolol hydrochloride

Discontinued Product

3288 has been discontinued.

View all Non-selective Adrenergic β Receptors products.
说明: Non-selective β antagonist
化学名: 1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol hydrochloride
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for Oxprenolol hydrochloride

Non-selective β-adrenergic antagonist.

技术数据 for Oxprenolol hydrochloride

分子量 301.81
公式 C15H23NO3.HCl
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 6452-73-9
Smiles CC(C)NCC(O)COC1=CC=CC=C1OCC=C.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for Oxprenolol hydrochloride

参考文献 for Oxprenolol hydrochloride

参考文献是支持产品生物活性的出版物。

Fujita et al (1998) Adrenergic agonists suppress the proliferation of microglia through β2-adrenergic receptor. Neuroscience Lett. 242 37

关键词: Oxprenolol hydrochloride, Oxprenolol hydrochloride supplier, Non-Selective, β-adrenoceptor, beta-adrenoceptor, b-adrenoceptor, antagonists, β-adrenergic, beta-adrenergic, b-adrenergic, Receptors, Non-selective, Adrenergic, Beta, 3288, Tocris Bioscience

篇 Oxprenolol hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Oxprenolol hydrochloride 的引用文献。

Oxprenolol hydrochloride 的评论

目前没有该产品的评论。 Be the first to review Oxprenolol hydrochloride and earn rewards!

Have you used Oxprenolol hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.